Upregulation of SSTR2 Expression and Radioligand Binding of [<sup>18</sup>F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1
Christoph J. Auernhammer(LMU Klinikum), Svenja Nölting(Queen Mary University of London)
Cited by 4
Related Papers
Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines
|Journal of Molecular Endocrinology|2012|41
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
|Cancers|2020|39
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
|Endocrine Connections|2017|32